Page 10 - Pascal Nigen News Today : Breaking News, Live Updates & Top Stories | Vimarsana

NLS Pharmaceutics AG: NLS Pharmaceutics Retains LifeSci Partners As Financial Advisor To Evaluate Strategic Partnering Initiatives

ZURICH, SWITZERLAND / ACCESSWIRE / March 31, 2022 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company focused on the discovery

United statesAlex zwyerKostenloser wertpapierhandelCindy rizzoPascal nigenExchange commissionAlpha bronzeWorld sleep congressEarly access programPharmaceutics ltdLifesci partnersChief executive officerSci partnersMazindol controlled releaseOrphan drug designations

NLS Pharmaceutics Retains LifeSci Partners As Financial Advisor To Evaluate Strategic Partnering Initiatives

NLS Pharmaceutics Retains LifeSci Partners As Financial Advisor To Evaluate Strategic Partnering Initiatives
newjerseytelegraph.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newjerseytelegraph.com Daily Mail and Mail on Sunday newspapers.

United statesAlex zwyerCindy rizzoPascal nigenExchange commissionAlpha bronzeWorld sleep congressEarly access programPharmaceutics ltdLifesci partnersChief executive officerSci partnersMazindol controlled releaseOrphan drug designationsRisk factorUnited states wire group

NLS Pharmaceutics Announces Early Access Program (EAP) Allowing Patients with Idiopathic Hypersomnia to Receive Treatment with Mazindol ER

NLS Pharmaceutics Announces Early Access Program (EAP) Allowing Patients with Idiopathic Hypersomnia to Receive Treatment with Mazindol ER
saltlakecitysun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from saltlakecitysun.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomAlex zwyerCindy rizzoPascal nigenHypersomnia foundationDrug administrationPharmaceutics ltdExchange commissionAlpha bronzeCaligor coghlan pharma servicesEuropean medicines agencyPatient programNamed patient programMazindol extended releaseIdiopathic hypersomnia

NLS Pharmaceutics AG: NLS Pharmaceutics to Participate in Maxim Group 2022 Virtual Growth Conference

ZURICH, SWITZERLAND / ACCESSWIRE / March 25, 2022 - NLS Pharmaceutics Ltd. (Nasdaq:NLSP, NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company focused on the discovery and development

United statesAlex zwyerKostenloser wertpapierhandelCindy rizzoPascal nigenExchange commissionMaxim groupAlpha bronzePharmaceutics ltdGrowth conferenceOrphan drug designations

NLS Pharmaceutics to Participate in Maxim Group 2022 Virtual Growth Conference

NLS Pharmaceutics to Participate in Maxim Group 2022 Virtual Growth Conference
saltlakecitysun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from saltlakecitysun.com Daily Mail and Mail on Sunday newspapers.

United statesAlex zwyerCindy rizzoPascal nigenExchange commissionMaxim groupAlpha bronzePharmaceutics ltdGrowth conferenceOrphan drug designationsRisk factorUnited states wire group